CVE:EMC

Emblem Stock Forecast, Price & News

$1.88
+0.03 (+1.62 %)
(As of 03/18/2019)
Add
Compare
Today's Range
$1.84
$1.88
50-Day Range
$1.85
$1.88
52-Week Range
$0.83
$2.12
Volume597,714 shs
Average Volume865,800 shs
Market Capitalization$245.45 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive EMC News and Ratings via Email

Sign-up to receive the latest news and ratings for Emblem and its competitors with MarketBeat's FREE daily newsletter.


About Emblem

Emblem Corp. produces, distributes, and sells medical cannabis and cannabis derivatives in Canada. The company also operates medical cannabis education centers to provide education services for making informed decisions about medical cannabis treatment options to physicians and patients. In addition, it provides various accessories. Emblem Corp. has a strategic partnership with GreenSpace Brands to develop and commercialize cannabidiol infused health and beauty products. The company is headquartered in Toronto, Canada.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

0.50 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Emblem (CVE:EMC) Frequently Asked Questions

What stocks does MarketBeat like better than Emblem?

Wall Street analysts have given Emblem a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Emblem wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Is Emblem a good dividend stock?

Emblem pays an annual dividend of $0.46 per share and currently has a dividend yield of 0.00%.
View Emblem's dividend history.

Who are Emblem's key executives?

Emblem's management team includes the following people:
  • Mr. Nicholas Dean, CEO, Pres & Director
  • Mr. Harvey Allan Shapiro, VP (Age 74)
  • Mr. Maxim Zavet, VP (Age 39)
  • Mr. John Harland Stewart, Advisory of Medical Division & Director
  • Mr. Gordon Howard Fox, Advisor

Who are some of Emblem's key competitors?

What other stocks do shareholders of Emblem own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Emblem investors own include Aurora Cannabis (ACB), Aphria (APHA), OrganiGram (OGI), ICC Labs (ICC), Canopy Growth (WEED), 22nd Century Group (XXII), Emerald Health Therapeutics (EMH), VIVO Cannabis (ABCN), Arena Pharmaceuticals (ARNA) and KKR & Co. Inc. (KKR).

What is Emblem's stock symbol?

Emblem trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EMC."

How do I buy shares of Emblem?

Shares of EMC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Emblem's stock price today?

One share of EMC stock can currently be purchased for approximately $1.88.

How much money does Emblem make?

Emblem has a market capitalization of $245.45 million and generates $5.71 million in revenue each year.

What is Emblem's official website?

The official website for Emblem is emblemcorp.com.

Where are Emblem's headquarters?

Emblem is headquartered at 36 York Mills Rd Suite 500, NORTH YORK, ON M2P 2E9, Canada.

How can I contact Emblem?

Emblem's mailing address is 36 York Mills Rd Suite 500, NORTH YORK, ON M2P 2E9, Canada. The company can be reached via phone at +1-647-2558106.


This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at c[email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.